Olorinab clinical trials
Also written APD371.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses olorinab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses olorinab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)TerminatedPhase 2Arena PharmaceuticalsNCT04043455Written as Olorinab
- Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal PainCompletedPhase 2Arena PharmaceuticalsNCT03155945Written as Olorinab
- Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel SyndromeTerminatedPhase 1Arena PharmaceuticalsNCT04655599Written as Olorinab
Codes
What other systems call olorinab · ClinicalTrials.gg INT002026
- UNII (FDA) 581F7DFA9BOLORINABConfirmed FDA, Wikidata
- Wikidata Q56615642olorinabConfirmed FDA, Wikidata
- NCI Thesaurus C166825OlorinabOne source FDA
- DrugBank DB14998One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 581F7DFA9B | OLORINAB | Confirmed FDA, Wikidata |
| Wikidata | Q56615642 | olorinab | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166825 | Olorinab | One source FDA |
| DrugBank | DB14998 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.